These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17979707)

  • 1. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
    Takai N; Narahara H
    Curr Med Chem; 2007; 14(24):2548-53. PubMed ID: 17979707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T; Takai N; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
    Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
    Takai N; Kawamata N; Gui D; Said JW; Miyakawa I; Koeffler HP
    Cancer; 2004 Dec; 101(12):2760-70. PubMed ID: 15536623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Anticancer Res; 2006; 26(2A):939-45. PubMed ID: 16619490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
    Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
    Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Gynecol Oncol; 2008 Apr; 109(1):107-14. PubMed ID: 18234298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nasu K; Narahara H
    Gynecol Oncol; 2008 Nov; 111(2):336-43. PubMed ID: 18790523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 Jan; 21(1):109-15. PubMed ID: 18097623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
    Ishii T; Kira N; Yoshida T; Narahara H
    Tumour Biol; 2013 Feb; 34(1):285-91. PubMed ID: 23150173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
    Takai N; Ueda T; Kawano Y; Nishida M; Nasu K; Narahara H
    Oncol Rep; 2005 Nov; 14(5):1287-91. PubMed ID: 16211298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Oncol Rep; 2008 Mar; 19(3):749-53. PubMed ID: 18288411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY; Jung JH; Na YJ; Kim HS
    Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2010 Jan; 25(1):97-103. PubMed ID: 19956907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer.
    Takai N; Narahara H
    Obstet Gynecol Int; 2010; 2010():923824. PubMed ID: 20169171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells.
    Xu S; Ren J; Chen HB; Wang Y; Liu Q; Zhang R; Jiang SW; Li J
    Curr Pharm Des; 2014; 20(11):1881-7. PubMed ID: 23888960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor therapy in epithelial ovarian cancer.
    Takai N; Narahara H
    J Oncol; 2010; 2010():458431. PubMed ID: 20052384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.